Drug intelligence / Profile preview

Bis(5-Amidino-2-Benzimidazolyl)Methanone

Development stage
Unknown
Modality
Small Molecules
01

Overview

Bis(5-Amidino-2-Benzimidazolyl)Methanone is an experimental small molecule compound with the molecular formula C17H14N8O and a molecular weight of approximately 346.3 g/mol[1][2][8]. It belongs to the class of aromatic diamidines and features two benzimidazole rings connected via a methanone (carbonyl) bridge. The compound has been studied primarily as an inhibitor of serine proteases, including tryptase and trypsin[4][10]. Its mechanism involves competitive inhibition at the active site of these enzymes, making it a potential lead for developing anticoagulant or anti-inflammatory agents[4][10]. However, there are no approved indications or advanced clinical trials for this molecule as of now; its use remains experimental.

Other names
2-(5-carbamimidoyl-1H-1,3-benzodiazole-2-carbonyl)-1H-1,3-benzodiazole-6-carboximidamide2,2'-carbonylbis(1h-benzimidazole-6-carboximidamide)SCHEMBL4314492SCHEMBL-4314492SCHEMBL 4314492SCHEMBL21067335SCHEMBL-21067335SCHEMBL 21067335AHIBAO
02

Targets

PRSS1 (Trypsin family)TPSB2 (Mast Cell Tryptase)

Beyond the preview

Go deeper on Bis(5-Amidino-2-Benzimidazolyl)Methanone.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Bis(5-Amidino-2-Benzimidazolyl)Methanone.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call